U.S. science policy needs to heed global realities

I have just returned from Singapore and Shanghai, where I visited life science research sites at universities, hospitals, pharmaceutical companies and Singapore’s Biopolis. These institutions, and the government support behind them, invite complex reflections on the situation in the United States.

The United States is home to academic, commercial and government research institutions that remain the envy of the world.